TY  - GEN
AU  - Sepriano,A
AU  - Ramiro,S
AU  - van der Heijde,D
AU  - Ávila-Ribeiro,P
AU  - Fonseca,R
AU  - Borges,J
AU  - Teixeira,L
AU  - Carvalho,P D
AU  - Cerqueira,M
AU  - Neves,J
AU  - Meirinhos,T
AU  - Barcelos,A
AU  - Sequeira,G
AU  - Salvador,M J
AU  - Canas da Silva,J
AU  - Santos,H
AU  - Bernardes,M
AU  - Vieira-Sousa,E
AU  - Canhão,H
AU  - Branco,J C
AU  - Pimentel-Santos,F
AU  - Landewé,R
TI  - Effect of Comedication With Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Retention of Tumor Necrosis Factor Inhibitors in Patients With Spondyloarthritis: A Prospective Cohort Study
SN  - 2326-5205
PY  - 2017///0711
KW  - Adalimumab
KW  - therapeutic use
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - Antirheumatic Agents
KW  - Blood Sedimentation
KW  - C-Reactive Protein
KW  - immunology
KW  - Cohort Studies
KW  - Deprescriptions
KW  - Drug Therapy, Combination
KW  - Etanercept
KW  - Female
KW  - Humans
KW  - Infliximab
KW  - Male
KW  - Middle Aged
KW  - Pain Measurement
KW  - Prospective Studies
KW  - Spondylarthritis
KW  - drug therapy
KW  - Spondylarthropathies
KW  - Time Factors
KW  - Tumor Necrosis Factor-alpha
KW  - adverse effects
N1  - Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/art.39772
ER  -